HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Smooth muscle-specific expression of calcium-independent phospholipase A2β (iPLA2β) participates in the initiation and early progression of vascular inflammation and neointima formation.

Abstract
Whether group VIA phospholipase A(2) (iPLA(2)β) is involved in vascular inflammation and neointima formation is largely unknown. Here, we report that iPLA(2)β expression increases in the vascular tunica media upon carotid artery ligation and that neointima formation is suppressed by genetic deletion of iPLA(2)β or by inhibiting its activity or expression via perivascular delivery of bromoenol lactone or of antisense oligonucleotides, respectively. To investigate whether smooth muscle-specific iPLA(2)β is involved in neointima formation, we generated transgenic mice in which iPLA(2)β is expressed specifically in smooth muscle cells and demonstrate that smooth muscle-specific expression of iPLA(2)β exacerbates ligation-induced neointima formation and enhanced both production of proinflammatory cytokines and vascular infiltration by macrophages. With cultured vascular smooth muscle cell, angiotensin II, arachidonic acid, and TNF-α markedly induce increased expression of IL-6 and TNF-α mRNAs, all of which were suppressed by inhibiting iPLA(2)β activity or expression with bromoenol lactone, antisense oligonucleotides, and genetic deletion, respectively. Similar suppression also results from genetic deletion of 12/15-lipoxygenase or inhibiting its activity with nordihydroguaiaretic acid or luteolin. Expression of iPLA(2protein in cultured vascular smooth muscle cells was found to depend on the phenotypic state and to rise upon incubation with TNF-α. Our studies thus illustrate that smooth muscle cell-specific iPLA(2)β participates in the initiation and early progression of vascular inflammation and neointima formation and suggest that iPLA(2)β may represent a novel therapeutic target for preventing cardiovascular diseases.
AuthorsShu Liu, Zhongwen Xie, Qingwei Zhao, Huan Pang, John Turk, Lindsay Calderon, Wen Su, Guogang Zhao, Haifei Xu, Ming C Gong, Zhenheng Guo
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 287 Issue 29 Pg. 24739-53 (Jul 13 2012) ISSN: 1083-351X [Electronic] United States
PMID22637477 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Oligonucleotides, Antisense
  • Angiotensin II
  • Phospholipases A2, Calcium-Independent
  • Calcium
Topics
  • Angiotensin II
  • Animals
  • Blotting, Western
  • Calcium (metabolism)
  • Carotid Arteries (immunology, metabolism)
  • Cells, Cultured
  • Immunohistochemistry
  • Inflammation (immunology, metabolism)
  • Mice
  • Mice, Knockout
  • Mice, Transgenic
  • Muscle, Smooth, Vascular (immunology, metabolism)
  • Neointima (immunology, metabolism)
  • Oligonucleotides, Antisense
  • Phospholipases A2, Calcium-Independent (genetics, metabolism)
  • Polymerase Chain Reaction
  • Promoter Regions, Genetic (genetics)
  • Rabbits
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: